Skip to main content
Zero Candida Technologies Incorporated logo

Zero Candida Technologies Incorporated — Investor Relations & Filings

Ticker · ZCT ISIN · CA9894831028 LEI · 64880FT2WN83O16KB106 TSXV Manufacturing
Open in API
Filings indexed 72 across all filing types
Latest filing 2025-03-29 Regulatory Filings
Country CA Canada
Listing TSXV ZCT

About Zero Candida Technologies Incorporated

https://zero-candida.com/

Zero Candida Technologies Incorporated is a FemTech medical device company focused on pioneering technology-driven solutions for unmet needs in women's health. The core offering is the Zero Candida platform, a novel diagnostic and therapeutic system designed for the non-drug treatment of candidiasis and other vaginal disorders. This smart device employs advanced artificial intelligence and personalized blue light therapy, adjusting light frequency based on individual patient assessment. The platform is engineered for high efficacy, claiming 99.99% fungal eradication within three hours. Furthermore, it integrates Hybrid Mobile Healthcare capabilities, enabling real-time data transmission for remote physician monitoring and telehealth consultation.

Recent filings

Filing Released Lang Actions
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is Form 52-109FV1, a CFO certification of the issuer’s annual filings under Canadian NI 52-109. It is not the actual Annual Report or MD&A, but a mandatory regulatory certificate accompanying the annual filings. It does not fit into any specific category like audit report, proxy statement, or earnings release, so it falls under the fallback Regulatory Filings category.
2025-03-29 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109FV1 “Venture Issuer Basic Certificate” under National Instrument 52-109, whereby the CEO certifies the accuracy of the annual filings (AIF, financial statements and MD&A). It is not the Annual Report itself, nor an MD&A, but a regulatory certification form. This does not fit any specific category like 10-K, IR, MDA, etc., and is a standalone regulatory filing. It therefore falls under the fallback “Regulatory Filings” category (RNS).
2025-03-29 English
Annual MD&A - English.pdf
Management Reports Classification · 1% confidence The document is titled “FORM 51-102F1 Management’s Discussion and Analysis for the year ended December 31, 2024.” It is a Canadian MD&A, providing management’s detailed explanation of operations, financial condition, forward-looking information, and business strategy. This corresponds to the Management Reports category.
2025-03-29 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 1% confidence The document is a completed Form 13-501F1 filed with the Alberta Securities Commission, including management certification and fee calculations for a reporting issuer. It is a regulatory form submission rather than an earnings release, financial report, or other specified category. No more specific category applies, so it falls under general Regulatory Filings (RNS).
2025-03-29 English
Audited annual financial statements – English.pdf
Audit Report / Information Classification · 1% confidence The document is a complete set of audited consolidated financial statements dated December 31, 2024, including the auditor’s report with opinion, basis for opinion, key audit matters, going‐concern discussion, and full notes to the financial statements. It does not include MD&A, shareholder letters, or strategic narrative typical of a full annual report, nor is it a brief announcement. It is therefore a standalone audit report and financial statements filing. Hence the correct classification is Audit Report / Information (AR). FY 2024
2025-03-29 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a press release announcing receipt of a patent and plans for a global patent portfolio. It is not an annual or interim financial report, management discussion, earnings release, share transaction, dividend notice, or other specified event. There is no indication of regulatory or financial material beyond an IP announcement, so it falls into the general “Regulatory Filings” fallback category (RNS).
2024-12-11 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.